Cybin Inc.

+$0.03 (+4.9%)
Closing price June 24, 2022
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.